Key Experts Highlight Emerging Scientific Data on Critical Role of Imaging in Prostate Cancer Care

Symposium Held by the Prostate Cancer Research Institute (PCRI) and AdMeTech Foundation Features Leading Physicians who Ask: Where is the Man-O-Gram™?

LOS ANGELES, March 21, 2011 /PRNewswire-USNewswire/ -- The following is being released by AdMeTech Foundation:

WHAT: AdMeTech and PCRI present a public symposium bringing together key medical experts to review state of the art, new discoveries and future vision for prostate cancer care. This event will highlight emerging research and innovation in imaging technologies and their profound impact on precisely-targeted, minimally-invasive approach to early detection and treatment of prostate cancer. This symposium brings into sharp focus the recent scientific data indicating that advanced imaging technologies can:

1. Improve early detection and accurately diagnose cancer missed on standard "blind" biopsies; and
2. Eliminate unnecessary and/or failed treatment causing life-altering complications to millions of men and adding billions of dollars to healthcare costs.

WHY: Prostate cancer is the most common major malignancy in the United States. While breast cancer strikes one in every eight women, prostate cancer strikes as many as one in every six men. Without accurate imaging tools akin to life-saving mammograms, prostate cancer has emerged as the second most lethal malignancy in men, even though it can be cured when detected early.

WHO: Faina Shtern, M.D., President, AdMeTech Foundation; Stan Brosman, M.D., Director of Research, PCRI; and Mark Scholz, M.D., Executive Director, PCRI will co-chair this symposium. Other speakers include: Duke Bahn, M.D., Director, Prostate Institute of America; Jelle Barentsz, M.D., Professor of Radiology, Radboud University, the Netherlands; Hossein Jadvar, M.D., Associate Professor of Radiology, University of South California; Daniel Margolis, M.D., Associate Clinical Professor of Radiology, UCLA; Leonard Marks, M.D., Professor of Urology, UCLA; and Howard M. Sandler, M.D., Chair of Radiation Oncology, Cedars-Sinai Medical Center.

WHEN & WHERE: Sunday, March 27, 2011, 3:00-7:00 p.m. Westin Hotel, 5400 Century Boulevard, Los Angeles (Near LAX).  

ABOUT Prostate Cancer Research Institute:  A Los Angeles-based not-for-profit organization with the mission to improve the quality of men's lives by supporting new, and potentially breakthrough, research and disseminating information that educates and empowers patients, families and the medical community. PCRI's founders believe that "providing insightful clinical research in combination with high level educational activities directed at both the patient and physician, would greatly enhance outcomes for prostate cancer patients everywhere."  

ABOUT AdMeTech Foundation: A Boston-based nonprofit organization providing international leadership for ground-breaking programs in research, education and public awareness to expedite advancement and implementation of imaging technologies for early detection and treatment of prostate cancer (www.admetech.org).  AdMeTech's public awareness campaign entitled, "Where is Our Manogram™?" was initiated in 2005 with the goal to end the prostate cancer crisis.  

SOURCE AdMeTech Foundation